Back to Search
DIVYA CHAUHAN, MD
MD
Clinical Neurophysiology Physician
NPI: 1205327962IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Neurophysiology PhysicianPrimary
Psychiatry & Neurology — Clinical Neurophysiology
Code: 2084N0600X
0101280351(VA)
CMS Specialties
PrimaryNEUROLOGY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.
PMID 18006697·Blood·2008
7-preclinical
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
PMID 17016430·Oncogene·2007
8-other
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
PMID 17032924·Blood·2007
7-preclinical
A novel proteasome inhibitor NPI-0052 as an anticancer therapy.
PMID 17047643·Br J Cancer·2006
6-review
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.
PMID 16286248·Cancer Cell·2005
4-observational
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
PMID 16166312·Cancer Res·2005
8-other
Proteasome inhibition in multiple myeloma: therapeutic implication.
PMID 15822185·Annu Rev Pharmacol Toxicol·2005
6-review
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance.
PMID 15070698·Blood·2004
8-other
Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of Bortezomib/Proteasome inhibitor PS-341.
PMID 15094775·Oncogene·2004
8-other
2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27.
PMID 15004512·Apoptosis·2004
8-other
Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells.
PMID 14559800·Cancer Res·2003
8-other
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells.
PMID 13679868·Oncogene·2003
8-other
Apoptotic signaling in multiple myeloma: therapeutic implications.
PMID 12953804·Int J Hematol·2003
6-review
Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance.
PMID 12855565·Blood·2003
8-other
Mechanisms of cell death and survival in multiple myeloma (MM): Therapeutic implications.
PMID 12815276·Apoptosis·2003
6-review
JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells.
PMID 12665525·J Biol Chem·2003
8-other
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
PMID 12200384·Blood·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44035 RIVERSIDE PKWY, LEESBURG, VA 20176
LEESBURG, VA 20176 - Phone
- (703) 858-6000
Quick Facts
- NPI
- 1205327962
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile